- Home
- ABEO vs TCMD Comparison
ABEO vs TCMD Comparison
Compare ABEO & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- TCMD
- Stock Information
- Founded
- ABEO 1974
- TCMD 1995
- Country
- ABEO United States
- TCMD United States
- Employees
- ABEO N/A
- TCMD N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- ABEO Health Care
- TCMD Health Care
- Exchange
- ABEO Nasdaq
- TCMD Nasdaq
- Market Cap
- ABEO 281.0M
- TCMD 300.1M
- IPO Year
- ABEO 1980
- TCMD 2016
- Fundamental
- Price
- ABEO $4.97
- TCMD $15.19
- Analyst Decision
- ABEO Strong Buy
- TCMD Buy
- Analyst Count
- ABEO 5
- TCMD 4
- Target Price
- ABEO $18.20
- TCMD $16.83
- AVG Volume (30 Days)
- ABEO 1.2M
- TCMD 151.9K
- Earning Date
- ABEO 11-13-2025
- TCMD 11-03-2025
- Dividend Yield
- ABEO N/A
- TCMD N/A
- EPS Growth
- ABEO N/A
- TCMD N/A
- EPS
- ABEO 0.99
- TCMD 0.63
- Revenue
- ABEO $400,000.00
- TCMD $298,851,000.00
- Revenue This Year
- ABEO N/A
- TCMD $8.65
- Revenue Next Year
- ABEO $324.71
- TCMD $8.66
- P/E Ratio
- ABEO $5.14
- TCMD $24.11
- Revenue Growth
- ABEO N/A
- TCMD 6.15
- 52 Week Low
- ABEO $3.93
- TCMD $8.61
- 52 Week High
- ABEO $7.54
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- ABEO 34.65
- TCMD 60.86
- Support Level
- ABEO $4.95
- TCMD $14.86
- Resistance Level
- ABEO $5.41
- TCMD $15.58
- Average True Range (ATR)
- ABEO 0.24
- TCMD 0.37
- MACD
- ABEO -0.02
- TCMD -0.01
- Stochastic Oscillator
- ABEO 1.33
- TCMD 67.09
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.